Cape Investment Advisory’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15K Buy
+253
New +$1.68K ﹤0.01% 1224
2026
Q1
Sell
-253
Closed -$1.77K 1095
2025
Q4
$1.77K Sell
253
-100
-28% -$783 ﹤0.01% 1122
2025
Q3
$2.73K Hold
353
﹤0.01% 629
2025
Q2
$3.08K Hold
353
﹤0.01% 857
2025
Q1
$2.81K Sell
353
-35
-9% -$354 ﹤0.01% 846
2024
Q4
$3.53K Hold
388
﹤0.01% 806
2024
Q3
$3.56K Sell
388
-81
-17% -$670 ﹤0.01% 766
2024
Q2
$4.59K Hold
469
﹤0.01% 680
2024
Q1
$7.08K Sell
469
-97
-17% -$1.76K ﹤0.01% 597
2023
Q4
$12.2K Hold
566
0.01% 622
2023
Q3
$10.5K Hold
566
0.01% 543
2023
Q2
$14.3K Sell
566
-30
-5% -$755 0.01% 492
2023
Q1
$15.4K Buy
+596
New +$15.9K 0.01% 466

Other funds holding TDOC

Cape Investment Advisory's TDOC Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Teladoc Health (TDOC) in Q2 2026: 253 shares worth $2.15K. The stake represents ﹤0.01% of the portfolio and ranks #1224 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in TDOC as recently as Q4 2025.

Cape Investment Advisory first reported a position in TDOC in Q1 2023 and has held it in 13 quarters since. The position peaked at $15.4K in Q1 2023. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Cape Investment Advisory held 253 shares of Teladoc Health worth $2.15K as of Q2 2026.
  • Teladoc Health was a new Cape Investment Advisory position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #1224 holding.
  • Cape Investment Advisory first reported a position in Teladoc Health in Q1 2023 and has held it in 13 quarters since.
  • Cape Investment Advisory's Teladoc Health position peaked at $15.4K in Q1 2023.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.